Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

FDA Expands Label of Oral HIV Drug to Newborns

(MedPage Today) -- The FDA expanded the approval of dolutegravir tablets for oral suspension (Tivicay PD) to include newborns with HIV infections younger than 4 weeks of age, the agency announced on Tuesday. In combination with other antiretroviral...

FDA Expands Label of Oral HIV Drug to Newborns

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Wednesday 26 August →